Page last updated: 2024-09-02

alpha-hydroxymetoprolol and Cardiovascular Diseases

alpha-hydroxymetoprolol has been researched along with Cardiovascular Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gu, HW; Li, SS; Liu, YJ; Su, ZY; Wu, HL; Yin, XL; Yu, RQ1
Ismail, R; Teh, LK1

Trials

1 trial(s) available for alpha-hydroxymetoprolol and Cardiovascular Diseases

ArticleYear
The relevance of CYP2D6 genetic polymorphism on chronic metoprolol therapy in cardiovascular patients.
    Journal of clinical pharmacy and therapeutics, 2006, Volume: 31, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Antihypertensive Agents; Cardiovascular Diseases; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Kidney Diseases; Male; Metoprolol; Middle Aged; Pharmacogenetics; Polymorphism, Genetic

2006

Other Studies

1 other study(ies) available for alpha-hydroxymetoprolol and Cardiovascular Diseases

ArticleYear
Simultaneous determination of metoprolol and α-hydroxymetoprolol in human plasma using excitation-emission matrix fluorescence coupled with second-order calibration methods.
    Bioanalysis, 2012, Volume: 4, Issue:23

    Topics: Adrenergic beta-1 Receptor Antagonists; Algorithms; Blood Chemical Analysis; Calibration; Cardiovascular Diseases; Humans; Kinetics; Metoprolol; Oxidation-Reduction; Spectrometry, Fluorescence

2012